Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-10

Clinical Trial Update: A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing the safety and effectiveness of topiramate versus phenytoin in patients with new-onset epilepsy requiring rapid initiation of a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DILANTIN (Phenytoin sodium, extended release)
  • Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED